Importance Detailed information about the association of COVID-19 with outcomes in pregnant
individuals compared with not-infected pregnant individuals is much needed. Objective …

This paper reviews current knowledge on the role of the long-chain polyunsaturated fatty
acids (LC-PUFA), docosahexaenoic acid (DHA, C22:6n-3) and arachidonic acid (AA, 20:4n-6), …

A European League Against Rheumatism (EULAR) task force was established to define
points to consider on use of antirheumatic drugs before pregnancy, and during pregnancy and …

… Berthold Koletzko and Irene Cetin were asked to coordinate the project and asked J.
Thomas Brenna to join the coordination committee. Based on an initial search and review of the …

Rheumatic diseases in women of childbearing years may necessitate drug treatment during
a pregnancy, to control maternal disease activity and to ensure a successful pregnancy …

The impact of SARS-CoV-2 infection during gestation remains unclear. Here, we analyse the
viral genome on maternal and newborns nasopharyngeal swabs, vaginal swabs, maternal …

Background It is unclear whether the suggested link between COVID-19 during pregnancy
and preeclampsia is an independent association or if these are caused by common risk …

Background The Factor V Leiden and prothrombin-gene mutations are independent risk
factors for venous thrombosis; it is debated whether a mutation in the gene encoding …

Unexplained intrauterine growth restriction of the fetus (IUGR) results from impaired
placental development, frequently associated with maternal malperfusion. Some cases are …

Background Fetuses with intrauterine growth retardation are delivered if they have evidence
of distress, as manifested by abnormalities in the fetal heart rate and umbilical-artery blood …